Clinical Trials for Cancer Treatment

Study Title:

MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX)

What is the purpose of the study? (in Layman's terms, please describe the study)

To have a registry of clinical data and information to be used to further our understanding.

Upstate Institutional Review Board (IRB) Number:

1256158

Study/Protocol ID:

FLEX Registry

Study Phase:

N/A

Patient Age Group:

Adults

Principal Investigator:

Sam Benjamin, MD

Who is eligible?

Newly diagnosed, stage I-III

What is involved if I participate?

• How long is the study?
  10 years
• Is transportation provided or reimbursed?
  No
• Is parking provided or reimbursed?
  No
• What tests and procedures are involved?
  N/A

Where will the study take place?

Upstate Cancer Center
Upstate at Community
Upstate at Oneida
Upstate at Oswego

Other Information:

This is a registry study and therefore no activities are associated with it. We would simply follow you and your treatment through your records.

Who can I contact for more information?

Name: Sienna Lee
Phone: 315-464-5934
Email: [email protected]

Return to Previous Page || Search Again